Close

Prof Pontiano Kaleebu

Professor of Immunovirology*

United Kingdom

Affiliations

MRC/UVRI and LSHTM Uganda Research Unit

Selected Publications

Dynamics of the blood plasma proteome during hyperacute HIV-1 infection.
Nazziwa, J; Freyhult, E; Hong, M-G; Johansson, E; Årman, F; Hare, J; Gounder, K; Rezeli, M; Mohanty, T; Kjellström, S; Kamali, A; Karita, E; Kilembe, W; Price, MA; KALEEBU, P; Allen, S; Hunter, E; Ndung'u, T; Gilmour, J; Rowland-Jones, SL; Sanders, E; Hassan, AS; Esbjörnsson, J;
2024
Nature communications
Gene expression of tight junctions in foreskin is not affected by HIV pre-exposure prophylaxis.
WEBB, EL; Petkov, S; Yun, H; Else, L; Lebina, L; Serwanga, J; Pillay, A-DA P; Seiphetlo, TB; Mugaba, S; Namubiru, P; Odoch, G; Opoka, D; SSEMATA, AS; KALEEBU, P; Khoo, S; Martinson, N; Fox, J; Gray, CM; Herrera, C; Chiodi, F;
2024
Frontiers in immunology
Emerging threat of artemisinin partial resistance markers (pfk13 mutations) in Plasmodium falciparum parasite populations in multiple geographical locations in high transmission regions of Uganda.
Agaba, BB; Travis, J; Smith, D; Rugera, SP; Zalwango, MG; Opigo, J; Katureebe, C; Mpirirwe, R; Bakary, D; ANTONIO, M; Khalid, B; Ngonzi, J; Kamya, MR; KALEEBU, P; PIOT, P; Cheng, Q;
2024
Malaria journal
The effect of BCG revaccination on the response to unrelated vaccines in urban Ugandan adolescents (POPVAC C): an open-label, randomised controlled trial.
Nassuuna, J; ZIRIMENYA, L; NKURUNUNGI, G; Natukunda, A; Zziwa, C; Ninsiima, C; Apule, B; Onen, C; Amongi, S; Serubanja, J; Tumwesige, P; Nsubuga, D; Amongin, R; Van Dam, GJ; Corstjens, PL A M; Kayiwa, J; Kabagenyi, J; Cose, S; WAJJA, A; KALEEBU, P; WEBB, EL; ELLIOTT, AM; POPVAC trial team,;
2024
The Lancet Global health
The effect of intensive praziquantel administration on vaccine-specific responses among schoolchildren in Ugandan schistosomiasis-endemic islands (POPVAC A): an open-label, randomised controlled trial.
NKURUNUNGI, G; Nassuuna, J; Natukunda, A; ZIRIMENYA, L; Walusimbi, B; Zziwa, C; Ninsiima, C; Kabagenyi, J; Kabuubi, PN; Van Dam, GJ; Corstjens, PL A M; Kayiwa, J; Kizza, M; Mutebe, A; Nakazibwe, E; Akello, FA; Sewankambo, M; Kiwanuka, S; Cose, S; WAJJA, A; KALEEBU, P; WEBB, EL; ELLIOTT, AM; POPVAC trial team,;
2024
The Lancet. Global health
Crimean-Congo hemorrhagic fever cases diagnosed during an outbreak of Sudan virus disease in Uganda, 2022-23.
Balinandi, S; Mulei, S; Whitmer, S; Nyakarahuka, L; Cossaboom, CM; Shedroff, E; Morales-Betoulle, M; Krapiunaya, I; Tumusiime, A; Kyondo, J; Baluku, J; Namanya, D; Torach, CR; Mutesi, J; Kiconco, J; Pimundu, G; Muyigi, T; Rowland, J; Nsawotebba, A; Ssewanyana, I; Muwanguzi, D; Kadobera, D; Harris, JR; Ario, AR; Atek, K; ... Klena, JD.
2024
PLoS neglected tropical diseases
Schistosome and malaria exposure and urban-rural differences in vaccine responses in Uganda: a causal mediation analysis using data from three linked randomised controlled trials.
Natukunda, A; NKURUNUNGI, G; ZIRIMENYA, L; Nassuuna, J; Zziwa, C; Ninsiima, C; Tumusiime, J; Nyanzi, R; Namutebi, M; Kiwudhu, F; Van Dam, GJ; Corstjens, PL A M; Kizindo, R; Nkangi, R; Kabagenyi, J; Nassanga, B; Cose, S; WAJJA, A; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global Health
The effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on vaccine-specific responses among schoolchildren in rural Uganda (POPVAC B): a double-blind, randomised controlled trial.
ZIRIMENYA, L; Natukunda, A; Nassuuna, J; NKURUNUNGI, G; Zziwa, C; Ninsiima, C; Kukundakwe, C; Nankabirwa, CM; Katushabe, C; Namusobya, LK; Oduru, G; Kabami, G; Kabali, J; Kayiwa, J; Kabagenyi, J; Van Dam, GJ; Corstjens, PL A M; Cose, S; WAJJA, A; Staedke, SG; KALEEBU, P; ELLIOTT, AM; WEBB, EL; POPVAC trial team,;
2024
The Lancet Global health
A Lipid Nanoparticle-Formulated Self-Amplifying RNA Rift Valley Fever Vaccine Induces a Robust Humoral Immune Response in Mice.
Kitandwe, PK; Rogers, P; Hu, K; Nayebare, O; Blakney, AK; McKay, PF; KALEEBU, P; Shattock, RJ;
2024
Vaccines
Next-Generation Sequencing Reveals a High Frequency of HIV-1 Minority Variants and an Expanded Drug Resistance Profile among Individuals on First-Line ART.
Nannyonjo, M; Omooja, J; Bugembe, DL; BBOSA, N; Lunkuse, S; Nabirye, SE; Nassolo, F; Namagembe, H; ABAASA, A; Kazibwe, A; KALEEBU, P; Ssemwanga, D;
2024
Viruses
See more information